OM
OUTSET MEDICAL (OM)
NASDAQ
$4.73+$0.13 (+2.72%)
Price as of Jun 03, 2026 4:24 PM EDT
  • $90.6M
    Market Cap
  • -73.88%
    1-Year Change
  • Medical Devices
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 37
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Stock Market Today: S&P 500, Nasdaq Futures Drop Despite Senate Passing Resolution To Reopen Government—Nvidia, Paramount Skydance In Focus (UPDATED)

U.S. stock futures fell on Tuesday after the Senate passed a resolution to reopen the government. Market attention was focused on several company earnings reports and potential Federal Reserve interest rate cuts.

11/11/2025, 8:32 AM • Benzinga

Stock Market Today: S&P 500, Nasdaq Futures Drop Despite Senate Passing Resolution To Reopen Government—Nvidia, Paramount Skydance In Focus

U.S. stock futures fell on Tuesday after the Senate passed a resolution to reopen the government. Markets are anticipating potential Federal Reserve interest rate cuts and watching key company earnings reports.

11/11/2025, 5:39 AM • Benzinga

Peers

Statistics

More
Day Range
$4.51
$5.06
$4.60
1-Year Range
$3.16
$21.24
$4.60
Latest Close$4.60
Change
-$0.47 (-10.22%)
Volume324,489
Market Cap$90.6M
Shares Outstanding18.5M
P/E (TTM)-0.001
Diluted EPS (TTM)-$4,156.61
Enterprise Value$157.0M

Information as of 06/03/2026

Company Profile

$90.6M
Market Cap
-$74.8M
Net Income
Sector: Healthcare
Industry: Medical Devices
3052 Orchard Drive, San Jose, CA, United States, 95134
669 231 8200

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Key Executives

  • Leslie L. Trigg
  • John L. Brottem
  • Marc Nash
  • Renee Gaeta
  • Dinamarie Stefani

Current Ownership Distribution

  • Institutions699.1M (68.41%)
  • Mutual Funds318.7M (31.19%)
  • Insiders4.1M (0.40%)
  • Other0 (0.00%)